Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Frizzled class receptor 9 (FZD9) is a G protein-coupled receptor that belongs to the frizzled family, characterized by seven transmembrane domains and serving as a receptor for Wnt signaling proteins. FZD9 is predominantly expressed in the brain, testis, eye, skeletal muscle, and kidney, and participates in canonical and non-canonical Wnt signaling, influencing cell proliferation, differentiation, bone formation, and neural development. The FZD9 gene is situated in the Williams syndrome critical region of chromosome 7, and hemizygous deletion is linked to Williams-Beuren syndrome. FZD9 functions by mediating Wnt ligand-induced activation of the beta-catenin pathway, regulating cellular processes essential for tissue development, neurogenesis, and regeneration, as well as contributing to disease mechanisms in several pathological conditions including cancers and developmental disorders.
Most mechanisms target the receptor’s role in the Wnt/beta-catenin signaling pathway, modulating cell proliferation, differentiation, or apoptosis via pathway activation or inhibition
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Frizzled class receptor 9 (FZD9).